Innate defenses of the intestinal epithelial barrier

Cellular and Molecular Life Sciences

Volumn 62, Issue 12, 2005, Pages 1297-1307

  Muller C A ^a   Autenrieth, I B ^b   Peschel, A ^b  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Antimicrobial peptides; Enteropathogens; Inflammatory bowel disease; Paneth cells; Pathogen associated molecular patterns; Pattern recognition receptors; Probiotics

Indexed keywords

ALPHA DEFENSIN; BETA DEFENSIN; BETA DEFENSIN 2; BETA DEFENSIN 3; CATHELICIDIN; CHEMOKINE; CHEMOKINE CCL20; CYTOKINE; DEFENSIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 2; INTERLEUKIN 8; LYSOZYME; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MELANOMA GROWTH STIMULATORY ACTIVITY FACTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; PEPTIDE; PHOSPHOLIPASE A2; PROBIOTIC AGENT; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; UNCLASSIFIED DRUG;

ANTIBIOTIC BIOSYNTHESIS; ANTIMICROBIAL ACTIVITY; BACILLI; BACTERIAL INFECTION; BACTERIOLYSIS; CANDIDA ALBICANS; CHRONIC INFLAMMATION; CROHN DISEASE; CYTOKINE PRODUCTION; ENTERITIS; ENTEROCOCCUS; ENTEROPATHY; ESCHERICHIA COLI; EXPERIMENTAL MOUSE; GIARDIA LAMBLIA; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOLOGY; INNATE IMMUNITY; INTESTINE; INTESTINE EPITHELIUM CELL; INTESTINE FLORA; INTESTINE FUNCTION; INTESTINE INFECTION; INTESTINE MUCOSA; LACTOBACILLUS; LEUKOCYTE; LISTERIA MONOCYTOGENES; NONHUMAN; PANETH CELL; PARASITOSIS; PATHOPHYSIOLOGY; PERMEABILITY BARRIER; PROTEIN FUNCTION; REVIEW; SALMONELLA ENTERICA; SHIGELLA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; TRICHINELLA SPIRALIS; ULCERATIVE COLITIS; YEAST;

ANIMALS; ANTI-INFECTIVE AGENTS; DEFENSINS; HUMANS; IMMUNE TOLERANCE; IMMUNITY, MUCOSAL; IMMUNITY, NATURAL; INTESTINAL MUCOSA; INTESTINES; RECEPTORS, CELL SURFACE;

EID: 20744443283     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-005-5034-2     Document Type: Review

References (111)

1. Smith G. and Gorbach S. (1995) Normal alimentary tract flora. In: Infections of the Gastrointestinal Tract, pp. 53-69, Blaser M., Smith J. and Ravidin J. (eds), Raven, New York, NY
2. Hao W. L. and Lee Y. K. (2004) Microflora of the gastrointestinal tract: a review. Methods Mol. Biol. 268: 491-502
3. Smith A. C. and Podolsky D. K. (1986) Colonic mucin glycoproteins in health and disease. Clin. Gastroenterol. 15: 815-837
4. Gusils C., Morata V. and Gonzalez S. (2004) Determination of bacterial adhesion to intestinal mucus. Methods Mol. Biol. 268: 411-415
5. MacDonald T. T. (2003) The mucosal immune system. Parasite Immunol. 25: 235-246
6. Fagarasan S. and Honjo T. (2003) Intestinal IgA synthesis: regulation of front-line body defences. Nat. Rev. Immunol. 3: 63-72
7. Autenrieth I. B. and Schmidt M. A. (2000) Bacterial interplay at intestinal mucosal surfaces: implications for vaccine development. Trends Microbiol. 8: 457-464
8. Porter E. M., Bevins C. L., Ghosh D. and Ganz T. (2002) The multifaceted Paneth cell. Cell. Mol. Life Sci. 59: 156-170
9. Ouellette A. J. (1999) IV. Paneth cell antimicrobial peptides and the biology of the mucosal barrier. Am. J. Physiol. 277: G257-G261
10. Ayabe T., Satchell D. P., Wilson C. L., Parks W. C., Selsted M. E. and Ouellette A. J. (2000) Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria. Nat. Immunol. 1: 113-118
11. Beil W. J., Weller P. F., Peppercorn M. A., Galli S. J. and Dvorak A. M. (1995) Ultrastructural immunogold localization of subcellular sites of TNF-alpha in colonic Crohn's disease. J. Leukoc. Biol. 58: 284-298
12. Yang D., Biragyn A., Kwak L. W. and Oppenheim J. J. (2002) Mammalian defensins in immunity: more than just microbicidal. Trends Immunol. 23: 291-296
13. Rumio C., Besusso D., Palazzo M., Selleri S., Sfondrini L., Dubini F. et al. (2004) Degranulation of paneth cells via toll-like receptor 9. Am. J. Pathol. 165: 373-381
14. Lala S., Ogura Y., Osborne C., Hor S. Y., Bromfield A., Davies S. et al. (2003) Crohn's disease and the NOD2 gene: a role for paneth cells. Gastroenterology 125: 47-57
15. Fahlgren A., Hammarstrom S., Danielsson A. and Hammarstrom M. L. (2003) Increased expression of antimicrobial peptides and lysozyme in colonic epithelial cells of patients with ulcerative colitis. Clin. Exp. Immunol. 131: 90-101
16. O'Neil D. A., Porter E. M., Elewaut D., Anderson G. M., Eckmann L., Ganz T. et al. (1999) Expression and regulation of the human beta-defensins hBD-1 and hBD-2 in intestinal epithelium. J. Immunol. 163: 6718-6724
17. Hase K., Eckmann L., Leopard J. D., Varki N. and Kagnoff M. F. (2002) Cell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epithelium. Infect. Immun. 70: 953-963
18. Weidenmaier C., Kristian S. A. and Peschel A. (2003) Bacterial resistance to antimicrobial host defenses - an emerging target for novel antiinfective strategies? Curr. Drug Targets 4: 643-649
19. Zasloff M. (2002) Antimicrobial peptides of multicellular organisms. Nature 415: 389-395
20. Ganz T. (2003) Defensins: antimicrobial peptides of innate immunity. Nat. Rev. Immunol. 3: 710-720
21. Peschel A. (2002) How do bacteria resist human antimicrobial peptides? Trends Microbiol. 10: 179-186
22. Ernst R. K., Guina T. and Miller S. I. (2001) Salmonella typhimurium outer membrane remodeling: role in resistance to host innate immunity. Microbes Infect. 3: 1327-1334
23. Lehrer R. I. and Ganz T. (1999) Antimicrobial peptides in mammalian and insect host defence. Curr. Opin. Immunol. 11: 23-27
24. Hill C. P., Yee J., Selsted M. E. and Eisenberg D. (1991) Crystal structure of defensin HNP-3, an amphiphilic dimer: mechanisms of membrane permeabilization. Science 251: 1481-1485
25. Skalicky J. J., Selsted M. E. and Pardi A. (1994) Structure and dynamics of the neutrophil defensins NP-2, NP-5, and HNP-1: NMR studies of amide hydrogen exchange kinetics. Proteins 20: 52-67
26. Diamond G., Russell J. P. and Bevins C. L. (1996) Inducible expression of an antibiotic peptide gene in lipopolysaccharide-challenged tracheal epithelial cells. Proc. Natl. Acad. Sci. USA 93: 5156-5160
27. Harder J., Bartels J., Christophers E. and Schröder J.-M. (1997) A peptide antibiotic from human skin. Nature 387: 861
28. Valore E. V. and Ganz T. (1992) Posttranslational processing of defensins in immature human myeloid cells. Blood 79: 1538-1544
29. Liu L., Zhao C., Heng H. H. and Ganz T. (1997) The human beta-defensin-1 and alpha-defensins are encoded by adjacent genes: two peptide families with differing disulfide topology share a common ancestry. Genomics 43: 316-320
30. Ouellette A. J., Pravtcheva D., Ruddle F. H. and James M. (1989) Localization of the cryptdin locus on mouse chromosome 8. Genomics 5: 233-239
31. Eisenhauer P. B. and Lehrer R. I. (1992) Mouse neutrophils lack defensins. Infect. Immun. 60: 3446-3447
32. Eisenhauer P. B., Harwig S. S. and Lehrer R. I. (1992) Cryptdins: antimicrobial defensins of the murine small intestine. Infect Immun. 60: 3556-3565
33. Ouellette A. J., Hsieh M. M., Nosek M. T., Cano-Gauci D. F., Huttner K. M., Buick R. N. et al. (1994) Mouse Paneth cell defensins: primary structures and antibacterial activities of numerous cryptdin isoforms. Infect. Immun. 62: 5040-5047
34. Ayabe T., Satchell D. P., Pesendorfer P., Tanabe H., Wilson C. L., Hagen S. J. et al. (2002) Activation of Paneth cell alpha-defensins in mouse small intestine. J. Biol. Chem. 277: 5219-5228
35. Wilson C. L., Ouellette A. J., Satchell D. P., Ayabe T., Lopez-Boado Y. S., Stratman J. L. et al. (1999) Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. Science 286: 113-117
36. Darmoul D., Brown D., Selsted M. E. and Ouellette A. J. (1997) Cryptdin gene expression in developing mouse small intestine. Am. J. Physiol. 272: G197-G206
37. Salmela M. T., Pender S. L., Karjalainen-Lindsberg M. L., Puolakkainen P., MacDonald T. T. and Saarialho-Kere U. (2004) Collagenase-1 (MMP-1), matrilysin-1 (MMP-7), and stromelysin-2 (MMP-10) are expressed by migrating enterocytes during intestinal wound healing. Scand. J. Gastroenterol. 39: 1095-1104
38. Ghosh D., Porter E., Shen B., Lee S. K., Wilk D., Drazba J. et al. (2002) Paneth cell trypsin is the processing enzyme for human defensin-5. Nat. Immunol. 3: 583-590
39. Molmenti E. P., Perlmutter D. H. and Rubin D. C. (1993) Cell-specific expression of alpha 1-antitrypsin in human intestinal epithelium. J. Clin. Invest. 92: 2022-2034
40. Cunliffe R. N., Rose F. R., Keyte J., Abberley L., Chan W. C. and Mahida Y. R. (2001) Human defensin 5 is stored in precursor form in normal Paneth cells and is expressed by some villous epithelial cells and by metaplastic Paneth cells in the colon in inflammatory bowel disease. Gut 48: 176-185
41. Cunliffe R. N. and Mahida Y. R. (2004) Expression and regulation of antimicrobial peptides in the gastrointestinal tract. J. Leukoc. Biol. 75: 49-58
42. Ouellette A. J., Darmoul D., Tran D., Huttner K. M., Yuan J. and Selsted M. E. (1999) Peptide localization and gene structure of cryptdin 4, a differentially expressed mouse paneth cell alpha-defensin. Infect. Immun. 67: 6643-6651
43. Mallow E. B., Harris A., Salzman N., Russell J. P., DeBerardinis R. J., Ruchelli E. et al. (1996) Human enteric defensins. Gene structure and developmental expression. J. Biol Chem 271: 4038-4045
44. Putsep K., Axelsson L. G., Boman A., Midtvedt T., Normark S., Boman H. G. et al. (2000) Germ-free and colonized mice generate the same products from enteric erodefensins. J. Biol. Chem. 275: 40478-40482
45. Kamal M., Wakelin D., Ouellette A. J., Smith A., Podolsky D. K. and Mahida Y. R. (2001) Mucosal T cells regulate Paneth and intermediate cell numbers in the small intestine of T. spiralis-infected mice. Clin. Exp. Immunol. 126: 117-125
46. Cunliffe R. N., Kamal M., Rose F. R., James P. D. and Mahida Y. R. (2002) Expression of antimicrobial neutrophil defensins in epithelial cells of active inflammatory bowel disease mucosa. J. Clin. Pathol. 55: 298-304
47. Muller C. A., Markovic-Lipkovski J., Klart T., Gamper J., Schwarz G., Beck H. et al. (2002) Human alpha-defensins HNPs-1, -2, and -3 in renal cell carcinoma: influences on tumor cell proliferation. Am. J. Pathol. 160: 1311-1324
48. Selsted M. E., Miller S. I., Henschen A. H. and Ouellette A. J. (1992) Enteric defensins: antibiotic peptide components of intestinal host defense. J. Cell Biol. 118: 929-936
49. Aley S. B., Zimmerman M., Hetsko M., Selsted M. E. and Gillin F. D. (1994) Killing of Giardia lamblia by cryptdins and cationic neutrophil peptides. Infect. Immun. 62: 5397-5403
50. Kagan B. L., Selsted M. E., Ganz T. and Lehrer R. I. (1990) Antimicrobial defensin peptides form voltage-dependent ion-permeable channels in planar lipid bilayer membranes. Proc. Natl. Acad. Sci. USA 87: 210-214
51. Lencer W. I. Cheung G., Strohmeier G. R., Currie M. G., Ouellette A. J., Selsted M. E. et al. (1997) Induction of epithelial chloride secretion by channel-forming cryptdins 2 and 3. Proc. Natl. Acad. Sci. USA 94: 8585-8589
52. Lin P. W., Simon P. O. Jr, Gewirtz A. T., Neish A. S., Ouellette A. J., Madara J. L. et al. (2004) Paneth cell cryptdins act in vitro as apical paracrine regulators of the innate inflammatory response. J. Biol. Chem. 279: 19902-19907
53. Garabedian E. M., Roberts L. J., McNevin M. S. and Gordon J. I. (1997) Examining the role of Paneth cells in the small intestine by lineage ablation in transgenic mice. J. Biol. Chem. 272: 23729-23740
54. Salzman N. H., Ghosh, D., Huttner K. M., Paterson Y. and Bevins C. L. (2003) Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature 422: 522-526
55. Schutte B. C., Mitros J. P., Bartlett J. A., Walters J. D., Jia H. P., Welsh M. J. et al. (2002) Discovery of five conserved beta-defensin gene clusters using a computational search strategy. Proc. Natl. Acad. Sci. USA 99: 2129-2133
56. Wehkamp J., Fellermann K., Herrlinger K. R., Baxmann S., Schmidt K., Schwind B. et al. (2002) Human beta-defensin 2 but not beta-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel disease. Eur. J. Gastroenterol. Hepatol. 14: 745-752
57. Fahlgren A., Hammarstrom S., Danielsson A. and Hammarstrom M. L. (2004) beta-Defensin-3 and -4 in intestinal epithelial cells display increased mRNA expression in ulcerative colitis. Clin. Exp. Immunol. 137: 379-385
58. O'Neil D. A., Cole S. P., Martin-Porter E., Housley M. P., Liu L., Ganz T. et al. (2000) Regulation of human beta-defensins by gastric epithelial cells in response to infection with Helicobacter pylori or stimulation with interleukin-1. Infect. Immun. 68: 5412-5415
59. Uehara N., Yagihashi A., Kondoh K., Tsuji N., Fujita T., Hamada H. et al. (2003) Human beta-defensin-2 induction in Helicobacter pylori-infected gastric mucosal tissues: antimicrobial effect of overexpression. J. Med. Microbiol. 52: 41-45
60. Chung W. O. and Dale B. A. (2004) Innate immune response of oral and foreskin keratinocytes: utilization of different signaling pathways by various bacterial species. Infect. Immun. 72: 352-358
61. Biragyn A., Surenhu M., Yang D., Ruffini P. A., Haines B. A., Klyushnenkova E. et al. (2001) Mediators of innate immunity that target immature, but not mature, dendritic cells induce antitumor immunity when genetically fused with nonimmunogenic tumor antigens. J. Immunol. 167: 6644-6653
62. Biragyn A., Ruffini P. A., Leifer C. A., Klyushnenkova E., Shakhov A., Chertov O. et al. (2002) Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science 298: 1025-1029
63. Vora P., Youdim A., Thomas L. S., Fukata M., Tesfay S. Y., Lukasek K. et al. (2004) beta-defensin-2 expression is regulated by TLR signaling in intestinal epithelial cells. J. Immunol. 173: 5398-5405
64. Zanetti M. (2004) Cathelicidins, multifunctional peptides of the innate immunity. J. Leukoc. Biol. 75: 39-48
65. Nizet V. and Gallo R. L. (2003) Cathelicidins and innate defense against invasive bacterial infection. Scand. J. Infect. Dis. 35: 670-676
66. Tollin M., Bergman P., Svenberg T., Jornvall H., Gudmundsson G. H. and Agerberth B. (2003) Antimicrobial peptides in the first line defence of human colon mucosa. Peptides 24: 523-530
67. Islam D., Bandholtz L., Nilsson J., Wigzell H., Christensson B., Agerberth B. et al. (2001) Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator. Nat. Med. 7: 180-185
68. Huttner K. M. and Ouellette A. J. (1994) A family of defensin-like genes codes for diverse cysteine-rich peptides in mouse Paneth cells. Genomics 24: 99-109
69. Hornef M. W., Putsep K., Karlsson J., Refai E. and Andersson M. (2004) Increased diversity of intestinal antimicrobial peptides by covalent dimer formation. Nat. Immunol. 5: 836-843
70. Canny G., Levy O., Furuta G. T., Narravula-Alipati S., Sisson R. B., Serhan C. N. et al. (2002) Lipid mediator-induced expression of bactericidal/ permeability-increasing protein (BPI) in human mucosal epithelia. Proc. Natl. Acad. Sci. USA 99: 3902-3907
71. Mannion B. A., Weiss J. and Elsbach P. (1990) Separation of sublethal and lethal effects of the bactericidal/permeability increasing protein on Escherichia coli. J. Clin. Invest. 85: 853-860
72. Elsbach P., Weiss J. and Levy O. (1994) Integration of antimicrobial host defenses: role of the bactericidal/permeability-increasing protein. Trends Microbiol. 2: 324-328
73. Ganz T. and Weiss J. (1997) Antimicrobial peptides of phagocytes and epithelia. Semin. Hematol. 34: 343-354
74. Izadpanah A., Dwinell M. B., Eckmann L., Varki N. M. and Kagnoff M. F. (2001) Regulated MIP-3alpha/CCL20 production by human intestinal epithelium: mechanism for modulating mucosal immunity. Am. J. Physiol. Gastrointest. Liver Physiol. 280: G710-G719
75. Yang D., Chen Q., Hoover D. M., Staley P., Tucker K. D., Lubkowski J. et al. (2003) Many chemokines including CCL20/MIP-3alpha display antimicrobial activity. J. Leukoc. Biol. 74: 448-455
76. Cole A. M., Ganz T., Liese A. M., Burdick M. D., Liu L. and Strieter R. M. (2001) Cutting edge: IFN-inducible ELR- CXC chemokines display defensin-like antimicrobial activity. J. Immunol.. 167: 623-627
77. Tang Y.-Q., Yeaman M. R. and Selsted M. E. (2002) Antimicrobial peptides from human platelets. Infect. Immun. 70: 6524-6533
78. Buckland A. G. and Wilton D. C. (2000) The antibacterial properties of secreted phospholipases A(2). Biochim. Biophys. Acta 1488: 71-82
79. Koprivnjak T., Peschel A., Gelb M. H., Liang N. S. and Weiss J. P. (2002) Role of charge properties of bacterial envelope in bactericidal action of human Group IIA phospholipase A2 against Staphylococcus aureus. J. Biol. Chem. 277: 47636-47644
80. Harwig S. S., Tan L., Qu X. D., Cho Y., Eisenhauer P. B. and Lehrer R. I. (1995) Bactericidal properties of murine intestinal phospholipase A2. J. Clin. Invest. 95: 603-610
81. Ganz T. (2004) Antimicrobial polypeptides. J. Leukoc. Biol. 75: 34-38
82. Masschalck B. and Michiels C. W. (2003) Antimicrobial properties of lysozyme in relation to foodborne vegetative bacteria. Crit. Rev. Microbiol. 29: 191-214
83. Salzman N. H., Chou M. M., de Jong H., Liu L., Porter E. M. and Paterson Y. (2003) Enteric Salmonella infection inhibits Paneth cell antimicrobial peptide expression. Infect. Immun. 71: 1109-1115
84. Dziarski R. (2003) Recognition of bacterial peptidoglycan by the innate immune system. Cell. Mol. Life Sci. 60: 1793-1804
85. Ogura Y., Bonen D. K., Inohara N., Nicolae D. L., Chen F. F., Ramos R. et al. (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411: 603-606
86. Ganz T., Gabayan V., Liao H. I., Liu L., Oren A., Graf T. et al. (2003) Increased inflammation in lysozyme M-deficient mice in response to Micrococcus luteus and its peptidoglycan. Blood 101: 2388-2392
87. Durr M. and Peschel A. (2002) Chemokines meet defensins - the merging concepts of chemoattractants and antimicrobial peptides in host defense. Infect. Immun. 70: 6515-6517
88. Chertov O., Michiel D. F., Xu L., Wang J. M., Tani K., Murphy W. J. et al. (1996) Identification of defensin-1, defensin-2, and CAP37/azurocidin as T cell chemoattractant proteins released from interleukin-8-stimulated neutrophils. J. Biol. Chem. 271: 2935-2940
89. Niyonsaba F., Iwabuchi K., Matsuda H., Ogawa H. and Nagaoka I. (2002) Epithelial cell-derived human beta-defensin-2 acts as a chemotaxin for mast cells through a pertussis toxin-sensitive and phospholipase C- dependent pathway. Int. Immunol. 14: 421-426
90. Yang D., Chertov O., Bykovskaia S. N., Chen Q., Buffo M. J., Shogan J. et al. (1999) Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 286: 525-528
91. Niyonsaba F., Iwabuchi K., Someya A., Hirata M., Matsuda H., Ogawa H. et al. (2002) A cathelicidin family of human antibacterial peptide LL-37 induces mast cell chemotaxis. Immunology 106: 20-26
92. Yang D., Chen Q., Schmidt A. P., Anderson G. M., Wang J. M., Wooters J. et al. (2000) LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J. Exp. Med. 192: 1069-1074
93. Perez-Canadillas J. M., Zaballos A., Gutierrez J., Varona R., Roncal F., Albar J. P. et al. (2001) NMR solution structure of murine CCE20/MIP-3alpha, a chemokine that specifically chemoattracts immature dendritic cells and lymphocytes through its highly specific interaction with the beta-chemokine receptor CCR6 . J. Biol. Chem. 276: 28372-28379
94. Hayashi F., Smith K. D., Ozinsky A., Hawn T. R. , Yi E. C., Goodlett D. R. et al. (2001) The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410: 1099-1103
95. Hornef M. W., Normark B. H., Vandewalle A. and Normark S. (2003) Intracellular recognition of lipopolysaccharide by toll-like receptor 4 in intestinal epithelial cells. J. Exp. Med. 198: 1225-1235
96. Schulte R., Grassl G. A., Preger S., Fessele S., Jacobi C. A., Schaller M. et al. (2000) Yersinia enterocolitica invasin protein triggers IL-8 production in epithelial cells via activation of Rel p65-p65 homodimers. FASEB J. 14: 1471-1484
97. Grassl G. A., Bonn E., Muller Y., Buhler O. T. and Autenrieth I. B. (2003) Interaction of Yersinia enterocolitica with epithelial cells: invasin beyond invasion. Int. J. Med. Microbiol. 293: 41-54
98. Cuzzola M., Mancuso G., Beninati C., Biondo C. , Genovese F., Tomasello F. et al. (2000) Beta 2 integrins are involved in cytokine responses to whole Gram-positive bacteria. J. Immunol. 164: 5871-5876
99. Jung H. C., Eckmann L., Yang S. K., Panja A., Fierer J., Morzycka-Wroblewska E. et al. (1995) A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J. Clin. Invest 95: 55-65
100. Abreu M. T., Thomas L. S., Arnold E. T., Lukasek K., Michelsen K. S. and Arditi M. (2003) TLR signaling at the intestinal epithelial interface. J. Endotoxin. Res. 9: 322-330
101. Melmed G., Thomas L. S., Lee N., Tesfay S. Y., Lukasek K., Michelsen K. S. et al. (2003) Human intestinal epithelial cells are broadly unresponsive to Toll-like receptor 2-dependent bacterial ligands: implications for host-microbial interactions in the gut. J. Immunol. 170: 1406-1415
102. Maaser C. and Kagnoff M. F. (2002) Role of the intestinal epithelium in orchestrating innate and adaptive mucosal immunity. Z. Gastroenterol. 40: 525-529
103. Fernandez M. I., Pedron T., Tournebize R., Olivo-Marin J. C., Sansonetti P. J. and Phalipon A. (2003) Anti-inflammatory role for intracellular dimeric immunoglobulin a by neutralization of lipopolysaccharide in epithelial cells. Immunity 18: 739-749
104. Swidsinski A., Ladhoff A., Pernthaler A., Swidsinski S., Loening-Baucke V., Ortner M. et al. (2002) Mucosal flora in inflammatory bowel disease. Gastroenterology 122: 44-54
105. Linskens R. K., Huijsdens X. W., Savelkoul P. H., Vandenbroucke-Grauls C. M. and Meuwissen S. G. (2001) The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics. Scand. J. Gastroenterol. Suppl 29-40
106. Waidmann M., Bechtold O., Frick J. S., Lehr H. A., Schubert S., Dobrindt U. et al. (2003) Bacteroides vulgatus protects against Escherichia coli-induced colitis in gnotobiotic interleukin-2-deficient mice. Gastroenterology 125: 162-177
107. Hugot J. P., Chamaillard M., Zouali H., Lesage S., Cezard J. P., Belaiche J. et al. (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411: 599-603
108. Bourlioux P., Koletzko B., Guarner F. and Braesco V. (2003) The intestine and its microflora are partners for the protection of the host: report on the Danone Symposium 'The Intelligent Intestine', held in Paris, June 14, 2002. Am. J. Clin. Nutr. 78: 675-683
109. Blum S. and Schiffrin E. J. (2003) Intestinal microflora and homeostasis of the mucosal immune response: implications for probiotic bacteria? Curr. Issues Intest. Microbiol. 4: 53-60
110. Tromm A., Niewerth U., Khoury M., Baestlein E. , Wilhelms G., Schulze J. et al. (2004) The probiotic E. coli strain Nissle 1917 for the treatment of collagenous colitis: first results of an open-label trial. Z. Gastroenterol. 42: 365-369
111. Rachmilewitz D., Katakura K., Karmeli F., Hayashi T., Reinus C., Rudensky B. et al. (2004) Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 126: 520-528